Study details
Enrolling now
V+PSF-M for Tobacco Cessation in HIV Care in India
University of Colorado, Denver
NCT IDNCT05786547ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
400
Study length
about 2.6 years
Ages
18+
Locations
1 site in CO
What this study is about
Researchers are testing a mobile behavioral program (PSF-M) and/or medication (Varenicline or other similar drugs) to help people with HIV quit smoking. The trial will last 932 days, and they are looking at how effective this approach is compared to standard care.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Positively Smoke Free Mobile (PSF-M)
- 2.Participate in Standard Care
- 3.Take Varenicline
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
varenicline
Drug routes
oral (Oral Tablet)
Body systems
Immune, Infectious